Byoung Kuk Jang , Ki Min Kwon , Woo Jin Chung , Kyung Sik Park , Kwang Bum Cho , Jae Seok Hwang , Sung Hoon Ahn , Gab Chul Kim , Young Hwan Kim , Jin Soo Choi , Jung Hye
Background/Aims There has been no standard treatment for advanced hepatocellular carcinoma (HCC) until now. The aim of this study was to evaluate the efficacy of hepatic arterial infusion therapy (HAIT) using 5-fluorouracil (5-FU) and cisplatin (CDDP) fo
Yun Ho Kong , Chul Ju Han , Sang Dae Lee , Wee Sik Sohn , Min Jae Kim , Seung Seog Ki , Jin Kim , Sook Hyang Jeong , You Cheoul Kim , Jhin Oh Lee , Gi Jeong Cheon ,
Background/Aims Hepatocellular carcinoma (HCC) is heterogenous in terms of its glucose metabolism. Positron emission tomography with fluorine-18-fluorodeoxyglucose (FDG-PET) shows various levels of FDG uptake for patients with HCC. This study was designe
Jae Hee Cheon , Joong Won Park , Kyung Woo Park , Young Il Kim , Sung Hoon Kim , Woo Jin Lee , Hong Suk Park , Sang Jae Park , Eun Kyoung Hong , Chang Min Kim
Background/Aims Hepatocellular carcinoma (HCC) is the third leading cause of cancer and the 5 year survival rate is 9.6% in Korea. To develop a strategy for surveillance and treatments, we studied the recent clinical characteristics of HCC diagnosed at s
First
Prev
